Influenza Drugs Market Report

Europe Influenza Drugs Market Size, Status and Forecast 2014-2026

  • POSTDATE：Dec 28, 2019
  • PAGES：154
  • REPORT CODE：GMM415289
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Influenza Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.2% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Influenza Drugs Market Segmentations:

    By Player:

    • Astrazeneca

    • BioCryst Pharmaceuticals

    • Emergent Biosolutions

    • Sanofi Pasteur

    • GlaxoSmithKline

    • CSL Limited

    • Serum Institute of India

    • Alvogen

    • Protein Sciences Corporation

    By Type:

    • Zanamivir

    • Oseltamivir Phosphate

    • Peramivir

    • Other

    By End-User:

    • Adults

    • Chidren

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Influenza Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Influenza Drugs Market Size and Growth Rate of Zanamivir from 2014 to 2026

    • 1.3.2 Europe Influenza Drugs Market Size and Growth Rate of Oseltamivir Phosphate from 2014 to 2026

    • 1.3.3 Europe Influenza Drugs Market Size and Growth Rate of Peramivir from 2014 to 2026

    • 1.3.4 Europe Influenza Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Influenza Drugs Market Size and Growth Rate of Adults from 2014 to 2026

    • 1.4.2 Europe Influenza Drugs Market Size and Growth Rate of Chidren from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Influenza Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Influenza Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Influenza Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Influenza Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Influenza Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Influenza Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Influenza Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Influenza Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Influenza Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Influenza Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Influenza Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Zanamivir

      • 3.4.2 Market Size and Growth Rate of Oseltamivir Phosphate

      • 3.4.3 Market Size and Growth Rate of Peramivir

      • 3.4.4 Market Size and Growth Rate of Other

    4 Segmentation of Influenza Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Influenza Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Influenza Drugs for Adults

      • 4.4.2 Market Size and Growth Rate of Influenza Drugs for Chidren

    5 Market Analysis by Major Regions

    • 5.1 Europe Influenza Drugs Production Analysis by Top Regions

    • 5.2 Europe Influenza Drugs Consumption Analysis by Top Regions

    • 5.3 Europe Influenza Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Influenza Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Influenza Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 France Influenza Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Influenza Drugs Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Influenza Drugs Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Influenza Drugs Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Influenza Drugs Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Influenza Drugs Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Influenza Drugs Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Influenza Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Influenza Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Influenza Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Influenza Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Influenza Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Influenza Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Influenza Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Influenza Drugs Landscape Analysis

    • 7.1 Germany Influenza Drugs Landscape Analysis by Major Types

    • 7.2 Germany Influenza Drugs Landscape Analysis by Major End-Users

    8. UK Influenza Drugs Landscape Analysis

    • 8.1 UK Influenza Drugs Landscape Analysis by Major Types

    • 8.2 UK Influenza Drugs Landscape Analysis by Major End-Users

    9. France Influenza Drugs Landscape Analysis

    • 9.1 France Influenza Drugs Landscape Analysis by Major Types

    • 9.2 France Influenza Drugs Landscape Analysis by Major End-Users

    10. Italy Influenza Drugs Landscape Analysis

    • 10.1 Italy Influenza Drugs Landscape Analysis by Major Types

    • 10.2 Italy Influenza Drugs Landscape Analysis by Major End-Users

    11. Spain Influenza Drugs Landscape Analysis

    • 11.1 Spain Influenza Drugs Landscape Analysis by Major Types

    • 11.2 Spain Influenza Drugs Landscape Analysis by Major End-Users

    12. Poland Influenza Drugs Landscape Analysis

    • 12.1 Poland Influenza Drugs Landscape Analysis by Major Types

    • 12.2 Poland Influenza Drugs Landscape Analysis by Major End-Users

    13. Russia Influenza Drugs Landscape Analysis

    • 13.1 Russia Influenza Drugs Landscape Analysis by Major Types

    • 13.2 Russia Influenza Drugs Landscape Analysis by Major End-Users

    14. Switzerland Influenza Drugs Landscape Analysis

    • 14.1 Switzerland Influenza Drugs Landscape Analysis by Major Types

    • 14.2 Switzerland Influenza Drugs Landscape Analysis by Major End-Users

    15. Turkey Influenza Drugs Landscape Analysis

    • 15.1 Turkey Influenza Drugs Landscape Analysis by Major Types

    • 15.2 Turkey Influenza Drugs Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Landscape Analysis by Top Countries

      • 16.3.1 Denmark Influenza Drugs Market Volume and Growth Rate

      • 16.3.2 Finland Influenza Drugs Market Volume and Growth Rate

      • 16.3.3 Norway Influenza Drugs Market Volume and Growth Rate

      • 16.3.4 Sweden Influenza Drugs Market Volume and Growth Rate

      • 16.3.6 Iceland Influenza Drugs Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Landscape Analysis by Top Countries

      • 17.3.1 Belgium Influenza Drugs Market Volume and Growth Rate

      • 17.3.2 Netherlands Influenza Drugs Market Volume and Growth Rate

      • 17.3.3 Luxembourg Influenza Drugs Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Landscape Analysis by Top Countries

      • 18.3.1 Estonia Influenza Drugs Market Volume and Growth Rate

      • 18.3.2 Latvia Influenza Drugs Market Volume and Growth Rate

      • 18.3.3 Lithuania Influenza Drugs Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Astrazeneca

      • 19.1.1 Astrazeneca Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 BioCryst Pharmaceuticals

      • 19.2.1 BioCryst Pharmaceuticals Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Emergent Biosolutions

      • 19.3.1 Emergent Biosolutions Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Sanofi Pasteur

      • 19.4.1 Sanofi Pasteur Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 GlaxoSmithKline

      • 19.5.1 GlaxoSmithKline Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 CSL Limited

      • 19.6.1 CSL Limited Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Serum Institute of India

      • 19.7.1 Serum Institute of India Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Alvogen

      • 19.8.1 Alvogen Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Protein Sciences Corporation

      • 19.9.1 Protein Sciences Corporation Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    The List of Tables and Figures (Totals 103 Figures and 115 Tables)

    • Figure Product Picture

    • Figure Europe Influenza Drugs Market Size and Growth Rate of Zanamivir from 2014 to 2026

    • Figure Europe Influenza Drugs Market Size and Growth Rate of Oseltamivir Phosphate from 2014 to 2026

    • Figure Europe Influenza Drugs Market Size and Growth Rate of Peramivir from 2014 to 2026

    • Figure Europe Influenza Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Europe Influenza Drugs Market Size and Growth Rate of Adults from 2014 to 2026

    • Figure Europe Influenza Drugs Market Size and Growth Rate of Chidren from 2014 to 2026

    • Figure Germany Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Influenza Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Influenza Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Influenza Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Influenza Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Influenza Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Zanamivir

    • Figure Market Size and Growth Rate of Oseltamivir Phosphate

    • Figure Market Size and Growth Rate of Peramivir

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Influenza Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Influenza Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Adults

    • Figure Market Size and Growth Rate of Chidren

    • Table Europe Influenza Drugs Production by Major Regions

    • Table Europe Influenza Drugs Production Share by Major Regions

    • Figure Europe Influenza Drugs Production Share by Major Countries and Regions in 2014

    • Table Europe Influenza Drugs Consumption by Major Regions

    • Table Europe Influenza Drugs Consumption Share by Major Regions

    • Table Germany Influenza Drugs Production, Import, Consumption and Export Analysis

    • Table UK Influenza Drugs Production, Import, Consumption and Export Analysis

    • Table France Influenza Drugs Production, Import, Consumption and Export Analysis

    • Table Italy Influenza Drugs Production, Import, Consumption and Export Analysis

    • Table Spain Influenza Drugs Production, Import, Consumption and Export Analysis

    • Table Poland Influenza Drugs Production, Import, Consumption and Export Analysis

    • Table Russia Influenza Drugs Production, Import, Consumption and Export Analysis

    • Table Switzerland Influenza Drugs Production, Import, Consumption and Export Analysis

    • Table Turkey Influenza Drugs Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Influenza Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Influenza Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Influenza Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Influenza Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Influenza Drugs Consumption by Types from 2014 to 2026

    • Table Germany Influenza Drugs Consumption Share by Types from 2014 to 2026

    • Table Germany Influenza Drugs Consumption by End-Users from 2014 to 2026

    • Table Germany Influenza Drugs Consumption Share by End-Users from 2014 to 2026

    • Table UK Influenza Drugs Consumption by Types from 2014 to 2026

    • Table UK Influenza Drugs Consumption Share by Types from 2014 to 2026

    • Table UK Influenza Drugs Consumption by End-Users from 2014 to 2026

    • Table UK Influenza Drugs Consumption Share by End-Users from 2014 to 2026

    • Table France Influenza Drugs Consumption by Types from 2014 to 2026

    • Table France Influenza Drugs Consumption Share by Types from 2014 to 2026

    • Table France Influenza Drugs Consumption by End-Users from 2014 to 2026

    • Table France Influenza Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Italy Influenza Drugs Consumption by Types from 2014 to 2026

    • Table Italy Influenza Drugs Consumption Share by Types from 2014 to 2026

    • Table Italy Influenza Drugs Consumption by End-Users from 2014 to 2026

    • Table Italy Influenza Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Spain Influenza Drugs Consumption by Types from 2014 to 2026

    • Table Spain Influenza Drugs Consumption Share by Types from 2014 to 2026

    • Table Spain Influenza Drugs Consumption by End-Users from 2014 to 2026

    • Table Spain Influenza Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Poland Influenza Drugs Consumption by Types from 2014 to 2026

    • Table Poland Influenza Drugs Consumption Share by Types from 2014 to 2026

    • Table Poland Influenza Drugs Consumption by End-Users from 2014 to 2026

    • Table Poland Influenza Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Russia Influenza Drugs Consumption by Types from 2014 to 2026

    • Table Russia Influenza Drugs Consumption Share by Types from 2014 to 2026

    • Table Russia Influenza Drugs Consumption by End-Users from 2014 to 2026

    • Table Russia Influenza Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Influenza Drugs Consumption by Types from 2014 to 2026

    • Table Switzerland Influenza Drugs Consumption Share by Types from 2014 to 2026

    • Table Switzerland Influenza Drugs Consumption by End-Users from 2014 to 2026

    • Table Switzerland Influenza Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Influenza Drugs Consumption by Types from 2014 to 2026

    • Table Turkey Influenza Drugs Consumption Share by Types from 2014 to 2026

    • Table Turkey Influenza Drugs Consumption by End-Users from 2014 to 2026

    • Table Turkey Influenza Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Influenza Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Influenza Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Influenza Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Influenza Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Influenza Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Influenza Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Influenza Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Influenza Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Influenza Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Influenza Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Influenza Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Astrazeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astrazeneca

    • Figure Sales and Growth Rate Analysis of Astrazeneca

    • Figure Revenue and Market Share Analysis of Astrazeneca

    • Table Product and Service Introduction of Astrazeneca

    • Table Company Profile and Development Status of BioCryst Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCryst Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of BioCryst Pharmaceuticals

    • Figure Revenue and Market Share Analysis of BioCryst Pharmaceuticals

    • Table Product and Service Introduction of BioCryst Pharmaceuticals

    • Table Company Profile and Development Status of Emergent Biosolutions

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent Biosolutions

    • Figure Sales and Growth Rate Analysis of Emergent Biosolutions

    • Figure Revenue and Market Share Analysis of Emergent Biosolutions

    • Table Product and Service Introduction of Emergent Biosolutions

    • Table Company Profile and Development Status of Sanofi Pasteur

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur

    • Figure Sales and Growth Rate Analysis of Sanofi Pasteur

    • Figure Revenue and Market Share Analysis of Sanofi Pasteur

    • Table Product and Service Introduction of Sanofi Pasteur

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of CSL Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Limited

    • Figure Sales and Growth Rate Analysis of CSL Limited

    • Figure Revenue and Market Share Analysis of CSL Limited

    • Table Product and Service Introduction of CSL Limited

    • Table Company Profile and Development Status of Serum Institute of India

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute of India

    • Figure Sales and Growth Rate Analysis of Serum Institute of India

    • Figure Revenue and Market Share Analysis of Serum Institute of India

    • Table Product and Service Introduction of Serum Institute of India

    • Table Company Profile and Development Status of Alvogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alvogen

    • Figure Sales and Growth Rate Analysis of Alvogen

    • Figure Revenue and Market Share Analysis of Alvogen

    • Table Product and Service Introduction of Alvogen

    • Table Company Profile and Development Status of Protein Sciences Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Protein Sciences Corporation

    • Figure Sales and Growth Rate Analysis of Protein Sciences Corporation

    • Figure Revenue and Market Share Analysis of Protein Sciences Corporation

    • Table Product and Service Introduction of Protein Sciences Corporation

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US